PMID- 8650724 OWN - NLM STAT- MEDLINE DCOM- 19960725 LR - 20190727 IS - 0039-2499 (Print) IS - 0039-2499 (Linking) VI - 27 IP - 6 DP - 1996 Jun TI - Confocal microscopic characterization of a lesion in a cerebral vessel of the stroke-prone spontaneously hypertensive rat. PG - 1118-22; discussion 1122-3 AB - BACKGROUND AND PURPOSE: Hypertension is a major risk factor for stroke and is associated with alterations in vascular structure and function. The aim of this study was to determine vascular function, wall morphology, and vascular smooth muscle cell (VSMC) arrangement in basilar arteries from stroke-prone spontaneously hypertensive rats (SHRSP) and normotensive control strain Wistar-Kyoto rats (WKY). The effect of perindopril treatment on SHRSP structure and function was also assessed. METHODS: VSMC orientation was determined with laser-scanning confocal microscopy and computer-assisted image processing in basilar arteries stained with 5(6)-carboxyfluorescein (wavelengths: excitation, 488; emission, 515) or propidium iodide (excitation, 529; emission, 550). Measurements of wall morphology and functional responses to serotonin and KCl were assessed with wire myography. RESULTS: In the WKY basilar arteries, VSMCs were uniformly oriented perpendicular to the longitudinal axis of the vessel, whereas in the SHRSP there were localized foci of VSMC geometric disorganization, with a significant deviation from 90 degrees. The SHRSP basilar arteries also showed structural remodeling and reduced contractile responses to serotonin and KCl. Perindopril treatment normalized blood pressure, prevented wall morphology alterations, and improved function but had no effect on VSMC disorganization. CONCLUSIONS: This is the first demonstration of lesions of VSMC geometric disorganization in a cerebral artery from a stroke-prone genetically hypertensive rat strain. These structural abnormalities are independent of blood pressure. Their functional sequel may play a role in the pathogenesis of stroke in this model. FAU - Arribas, S M AU - Arribas SM AD - Clinical Research Initiative in Heart Failure, University of Glasgow, UK. s.arribas@biomed.gla.ac.uk FAU - Gordon, J F AU - Gordon JF FAU - Daly, C J AU - Daly CJ FAU - Dominiczak, A F AU - Dominiczak AF FAU - McGrath, J C AU - McGrath JC LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Stroke JT - Stroke JID - 0235266 RN - 0 (Angiotensin-Converting Enzyme Inhibitors) RN - 0 (Antihypertensive Agents) RN - 0 (Coloring Agents) RN - 0 (Fluoresceins) RN - 0 (Fluorescent Dyes) RN - 0 (Indoles) RN - 0 (Vasoconstrictor Agents) RN - 3301-79-9 (6-carboxyfluorescein) RN - 333DO1RDJY (Serotonin) RN - 36015-30-2 (Propidium) RN - 660YQ98I10 (Potassium Chloride) RN - Y5GMK36KGY (Perindopril) SB - IM MH - Angiotensin-Converting Enzyme Inhibitors/pharmacology MH - Animals MH - Antihypertensive Agents/pharmacology MH - Basilar Artery/drug effects/*pathology/physiopathology MH - Blood Pressure/drug effects MH - Cerebrovascular Disorders/*pathology/physiopathology MH - Coloring Agents MH - Female MH - Fluoresceins MH - Fluorescent Dyes MH - Image Processing, Computer-Assisted MH - Indoles/pharmacology MH - Male MH - Microscopy, Confocal MH - Muscle, Smooth, Vascular/drug effects/pathology/physiopathology MH - Perindopril MH - Potassium Chloride/pharmacology MH - Propidium MH - Rats MH - Rats, Inbred SHR MH - Rats, Inbred WKY MH - Serotonin/pharmacology MH - Vasoconstrictor Agents/pharmacology EDAT- 1996/06/01 00:00 MHDA- 1996/06/01 00:01 CRDT- 1996/06/01 00:00 PHST- 1996/06/01 00:00 [pubmed] PHST- 1996/06/01 00:01 [medline] PHST- 1996/06/01 00:00 [entrez] AID - 10.1161/01.str.27.6.1118 [doi] PST - ppublish SO - Stroke. 1996 Jun;27(6):1118-22; discussion 1122-3. doi: 10.1161/01.str.27.6.1118.